Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
Aastrom Biosciences' CFO to Present at Noble Financial Group Small Cap Conference Ann Arbor, Michigan, September 21, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that Gerald D. Brennan, Jr., Vice President Administrative & Financial Operations and Chief Financial Officer, will
Aastrom Biosciences to Present at Merriman Curhan Ford & Co. 3rd Annual Investor Summit Ann Arbor, Michigan, September 14, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, Gerald D.
Ann Arbor, Michigan, September 13, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today reported financial results for the fourth quarter and fiscal year ended June 30, 2006. The Company also reported several clinical and operational achievements during the quarter, including: Completion of the
Webcast Alert: Aastrom Biosciences Announces Its Fourth Quarter Investor Conference Call Ann Arbor, MI, September 6, 2006 -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences, Inc. Fourth Quarter Fiscal Year End 2006 Investor Conference Call When:
